Group One Trading’s Aegerion Pharmaceuticals AEGR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-48,800
Closed -$145K 5194
2016
Q3
$145K Buy
48,800
+24,900
+104% +$43.2K ﹤0.01% 2693
2016
Q2
$36K Buy
23,900
+8,800
+58% +$20.1K ﹤0.01% 3511
2016
Q1
$56K Sell
15,100
-13,200
-47% -$81.8K ﹤0.01% 3202
2015
Q4
$286K Sell
28,300
-6,000
-17% -$72.2K ﹤0.01% 2234
2015
Q3
$466K Buy
34,300
+23,400
+215% +$417K 0.01% 1834
2015
Q2
$207K Sell
10,900
-20,300
-65% -$439K ﹤0.01% 2501
2015
Q1
$817K Sell
31,200
-1,500
-5% -$38.2K 0.01% 1237
2014
Q4
$685K Sell
32,700
-12,300
-27% -$310K 0.01% 1321
2014
Q3
$1.5M Buy
45,000
+11,300
+34% +$351K 0.02% 864
2014
Q2
$1.08M Sell
33,700
-55,600
-62% -$2.07M 0.02% 1085
2014
Q1
$4.12M Buy
89,300
+3,000
+3% +$176K 0.07% 299
2013
Q4
$6.12M Buy
86,300
+22,900
+36% +$1.75M 0.09% 201
2013
Q3
$5.43M Sell
63,400
-59,900
-49% -$5.08M 0.1% 194
2013
Q2
$7.81M Buy
+123,300
New +$6.55M 0.19% 95

Group One Trading's AEGR Position: Q3 2016 in Review

Group One Trading sold out of Aegerion Pharmaceuticals (AEGR) in Q3 2016, closing a stake of 14,362 shares — an estimated $24.9K sold.

Group One Trading first reported a position in AEGR in Q2 2013 and held it in 10 quarters. The position peaked at $4.11M in Q2 2013. 58 funds tracked by Wall St. Rank hold AEGR as of Q3 2016.

  • Group One Trading reported no remaining Aegerion Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
  • Group One Trading sold 14,362 Aegerion Pharmaceuticals shares in Q3 2016, an estimated $24.9K.
  • Group One Trading first reported a position in Aegerion Pharmaceuticals in Q2 2013 and held it in 10 quarters.
  • Group One Trading's Aegerion Pharmaceuticals position peaked at $4.11M in Q2 2013.
  • 58 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q3 2016.

Based on Group One Trading's 13F filing for Q3 2016, filed 14 Nov 2016.